Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens

by Tasker Sybil, Crum-Cianflone Nancy, Riddle Mark, Golub Elizabeth T, Benning Lorie, Ganesan Anuradha, Jacobson Lisa, Gange Stephen J
Published 2009-06-01

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort

by Marconi Vincent C, Dolan Matthew J, Eberly Lynn E, Krantz Elizabeth M, Lifson Alan R, Weintrob Amy C, Crum-Cianflone Nancy F, Ganesan Anuradha, Grambsch Patricia L, Agan Brian K
Published 2011-01-01

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study

by Ganesan Anuradha, Birbeck Gretchen L, Simpson David M, George Jomy M, French Jacqueline A, Grandits Greg A, Okulicz Jason F, Weintrob Amy C, Crum-Cianflone Nancy, Lalani Tahaniyat, Landrum Michael L
Published 2011-05-01

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort

by Lifson Alan R, Krantz Elizabeth M, Grambsch Patricia L, Macalino Grace E, Crum-Cianflone Nancy F, Ganesan Anuradha, Okulicz Jason F, Eaton Anne, Powers John H, Eberly Lynn E, Agan Brian K
Published 2012-02-01

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

by Ganesan Anuradha, Landrum Michael L, Chun Helen, Weintrob Amy C, Grandits Greg A, Marconi Vincent C, Okulicz Jason F, Crum-Cianflone Nancy, O'Connell Robert J, Lifson Alan, Wortmann Glenn W, Agan Brian K
Published 2010-05-01